Global In-Vitro Colorectal Cancer Screening Tests Market Growth (Status and Outlook) 2022-2028

As the global economy mends, the 2021 growth of In-Vitro Colorectal Cancer Screening Tests will have significant change from previous year. According to our (researcher) latest study, the global In-Vitro Colorectal Cancer Screening Tests market size is USD million in 2022 from USD 1022.2 million in 2021, with a change of % between 2021 and 2022. The global In-Vitro Colorectal Cancer Screening Tests market size will reach USD 1507.3 million in 2028, growing at a CAGR of 5.7% over the analysis period.
The United States In-Vitro Colorectal Cancer Screening Tests market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global In-Vitro Colorectal Cancer Screening Tests market, reaching US$ million by the year 2028. As for the Europe In-Vitro Colorectal Cancer Screening Tests landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main In-Vitro Colorectal Cancer Screening Tests players cover Alere(Abbott), Beckman Coulter, Siemens Healthcare, and Eiken Chemical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of In-Vitro Colorectal Cancer Screening Tests market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Biomarker Tests
Fecal Occult Blood Tests
CRC DNA Screening Tests
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital and Clinics
Ambulatory
Home Care
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Alere(Abbott)
Beckman Coulter
Siemens Healthcare
Eiken Chemical
Hitachi Chemical (Kyowa Medex)
Clinical Genomics Pty Ltd (Quest Diagnostics)
Sysmex
QIAGEN
R-Biopharm
Immunostics